GXFC3
Generic Name: lamivudine/zidovudine
Pill imprint GXFC3 has been identified as Combivir 150 mg / 300 mg.
Combivir is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy.
Combivir 150 mg / 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Combivir Images
- Generic Name:
- lamivudine/zidovudine
- Imprint:
-
GXFC3
- Strength:
- 150 mg / 300 mg
- Color:
- White
- Size:
- 17.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
hypromellose
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide
- Drug Class:
- Antiviral combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00173-0595
Advertisement
More Combivir resources
Search Again
